Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-06-21
2005-06-21
McKenzie, Thomas C. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252140, C514S252180, C514S252190, C514S252200, C514S275000, C544S122000, C544S295000, C544S323000, C544S324000
Reexamination Certificate
active
06908920
ABSTRACT:
Compounds of formula (I), wherein R1, p, R2, q, R3and R4are defined within, and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-blooded animal, such as man
REFERENCES:
patent: 4983608 (1991-01-01), Effland et al.
patent: 5516775 (1996-05-01), Zimmermann et al.
patent: 5521184 (1996-05-01), Zimmermann
patent: 5610303 (1997-03-01), Kimura et al.
patent: 5739143 (1998-04-01), Adams et al.
patent: 5859041 (1999-01-01), Liverton et al.
patent: 6593326 (2003-07-01), Bradbury et al.
patent: 2231765 (1998-09-01), None
patent: 0 135 472 (1985-03-01), None
patent: 0 363 002 (1990-04-01), None
patent: 0 379 806 (1990-08-01), None
patent: 0 945 443 (1999-09-01), None
patent: 91/18887 (1991-12-01), None
patent: 92/20642 (1992-11-01), None
patent: 95/09847 (1995-04-01), None
patent: 95/09851 (1995-04-01), None
patent: 95/09852 (1995-04-01), None
patent: 95/09853 (1995-04-01), None
patent: 95/15952 (1995-06-01), None
patent: 96/05177 (1996-02-01), None
patent: 96/28427 (1996-09-01), None
patent: 96/40143 (1996-12-01), None
patent: 97/19065 (1997-05-01), None
patent: 97/35856 (1997-10-01), None
patent: 97/40017 (1997-10-01), None
patent: 97/44326 (1997-11-01), None
patent: 97/47618 (1997-12-01), None
patent: 98/11095 (1998-03-01), None
patent: 98/16230 (1998-04-01), None
patent: 98/18782 (1998-05-01), None
patent: 98/25619 (1998-06-01), None
patent: 98/33798 (1998-08-01), None
patent: 98/41512 (1998-09-01), None
patent: 98/54093 (1998-12-01), None
patent: 98/56788 (1998-12-01), None
patent: 99/01136 (1999-01-01), None
patent: 99/32121 (1999-01-01), None
patent: 99/18096 (1999-04-01), None
patent: 99/18942 (1999-04-01), None
patent: 99/31073 (1999-06-01), None
patent: 99/41253 (1999-08-01), None
patent: 99/50250 (1999-10-01), None
patent: 99/50251 (1999-10-01), None
patent: 00/12485 (2000-03-01), None
patent: 00/12486 (2000-03-01), None
patent: 00/17202 (2000-03-01), None
patent: 00/17203 (2000-03-01), None
patent: 00/21926 (2000-04-01), None
patent: 00/25780 (2000-05-01), None
patent: 00/26209 (2000-05-01), None
patent: 00/39101 (2000-07-01), None
patent: 00/44750 (2000-08-01), None
patent: 00/49018 (2000-08-01), None
patent: 00/53595 (2000-09-01), None
patent: 00/55161 (2000-09-01), None
patent: 00/59892 (2000-10-01), None
patent: 00/78731 (2000-12-01), None
patent: 01/14375 (2001-03-01), None
patent: 01/29009 (2001-04-01), None
patent: 01/30778 (2001-05-01), None
patent: 01/37835 (2001-05-01), None
patent: 01/47897 (2001-07-01), None
patent: 01/47921 (2001-07-01), None
patent: 01/60816 (2001-08-01), None
patent: 01/64653 (2001-09-01), None
patent: 01/64654 (2001-09-01), None
patent: 01/64655 (2001-09-01), None
patent: 01/64656 (2001-09-01), None
patent: 01/72717 (2001-10-01), None
patent: 02/20512 (2002-03-01), None
patent: 02/066481 (2002-08-01), None
patent: 02/096887 (2002-12-01), None
Draetta, G. and Pagano, M. in “Annual Reports in Medicinal Chemistry, vol. 31”, 1996, Academic Press, San Diego, p 241-246.
S. Mani; C. Wang; K. Wu; R. Francis; R. Pestell Expert Opinion on Investigational Drugs 2000, vol. 9, No. 8, pp. 1849-1870, abstract only.
Kimball, D.S. et al, Ann. Reports Med. Chem., vol. 36, 2001, pp. 139-148.
J. Dumas, Expert Opinion on Therapeutic Patents, 2001, vol. 11, No. 3, pp. 405-429, abstract only.
Boschelli et al., “Synthesis A. Tyrosine Kinase Inhibitory Activity of A Serie of 2-Amino-8H-Pyrido′2,3-Dipyridmidines:”, Journal of Medicinal Chemistry, vol. 41, No. 22, 1998, pp. 4365-4377.
U.S. Appl. No. 09/763,705, filed Feb. 26, 2001, Breault et al., PCT Publication No. WO 00/12485, PCT Publication Date Mar. 9, 2000.
U.S. Appl. No. 09/763,681, filed Feb. 26, 2001, Breault et al., PCT Publication No. WO 00/12486, PCT Publication Date Mar. 9, 2000.
U.S. Appl. No. 09/868,602, filed Jun. 20, 2001, PCT Publication No. WO 00/39101, PCT Publication Date Jul. 6, 2000.
U.S. Appl. No. 09/914,788, filed Sep. 5, 2001, Breault et al., PCT Publication No. WO 00/53595, PCT Publication Date Sep. 14, 2000.
U.S. Appl. No. 09/958,077, filed Oct. 4, 2001, Breault, PCT Publication No. WO 00/59892, PCT Publication Date Oct. 12, 2000.
U.S. Appl. No. 10/203,154 (allowed Jun. 27, 2003), filed Aug. 6, 2002, Pease et al., PCT Publication No. WO 01/64655, PCT Publication Date Sep. 7, 2001.
U.S. Appl. No. 10/220,139, filed Aug. 28, 2002, Pease et al., PCT Publication No. WO 01/64654, PCT Publication Date Sep. 7, 2001.
U.S. Appl. No. 10/203,025, filed Aug. 5, 2002, Pease et al., PCT Publication No. WO 01/64656, PCT Publication Date Sep. 7, 2001.
U.S. Appl. No. 10/203,549, filed Aug. 8, 2002, Pease et al., PCT Publication No. WO 01/64653, PCT Publication Date Sep. 7, 2001.
U.S. Appl. No. 10/069,019, filed Feb. 21, 2002, Thomas et al., PCT Publication No. WO 01/14375 A1, PCT Publication Date Mar. 1, 2001.
U.S. Appl. No. 10/239,790, filed Sep. 25, 2002, Thomas, PCT Publication No. WO 01/72717, PCT Publication Date Oct. 4, 2001.
U.S. Appl. No. 10/363,655, filed Mar. 4, 2003, Breault et al., PCT Publication No. WO 02/20512, PCT Publication Date Mar. 14, 2002.
U.S. Appl. No. 10/467,886, filed Aug. 13, 2003, Thomas, PCT Publication No. WO 02/066481 A1, PCT Publication Date Aug. 29, 2002.
Deady et al., “Reactions of some Quinazoline Compounds with Ethoxymethylenemalonic Acid Derivatives”, J. Heterocyclic Chem., vol. 26, 1989, pp. 161-168.
El-Kerdawy et al.; “2,4-Bis (Substituted)-5-Nitropyrimidines of Expected Diuretic Action”; Egypt J. Chem. vol. 29, No. 1986, pp. 247-251.
Fiziol Akt Veshchestva, 1975, vol. 7, pp. 68-72.
Ghosh et al.; “2,4-Bis(arylamino)-5-methylprimidines as Antimicrobial Agents”; J. Med. Chem., 1967, vol. 10, No. 5, pp. 974-975.
Ghosh, “2,4-Bis(arylamino)-6-methylpyrimidines as an antimicrobial agents”, Chemical Abstract No. 97712f, vol. 95, 1981, p. 648.
Schmidt et al.; “A Convenient Synthesis of 2-substituted 4-Amino-5-pyrimidinecarbonitriles”; J. Heterocycle Chem., 1997, vol. 24, No. 5, pp. 1305-1307.
Zimmermann et al., Phenylamino-Pyrimidine (PAP) Derivatives: A New Class of Potent and Selective Inhibitors of Protein Kinase C (PKC), Arch. Pharm. Pharm. Med. Chem., vol. 329, 1996, pp. 371-376.
Heaton David William
Newcombe Nicholas John
Thomas Andrew Peter
AstraZeneca AB
McKenzie Thomas C.
Morgan & Lewis & Bockius, LLP
LandOfFree
Pyrimidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3495532